Back to article: Immune system activation by natural products and complex fractions: a network pharmacology approach in cancer treatment
45. Ren Y, Wei M, Still PC, Yuan S, Deng Y, Chen X, Himmeldirk K, Kinghorn AD, Yu J (2012). Synthesis and Antitumor Activity of Ellagic Acid Peracetate. ACS Med Chem Lett 3(8): 631-636. 10.1021/ml300065z
46. Li X, Dong W, Nalin AP, Wang Y, Pan P, Xu B, Zhang Y, Tun S, Zhang J, Wang LS, He X, Caligiuri MA, Yu J (2018). The natural product chitosan enhances the anti-tumor activity of natural killer cells by activating dendritic cells. Oncoimmunology 7(6): e1431085. 10.1080/2162402X.2018.1431085
47. Deng Y, Chu J, Ren Y, Fan Z, Ji X, Mundy-Bosse B, Yuan S, Hughes T, Zhang J, Cheema B, Camardo AT, Xia Y, Wu LC, Wang LS, He X, Kinghorn AD, Li X, Caligiuri MA, Yu J (2014). The natural product phyllanthusmin C enhances IFN-gamma production by human NK cells through upregulation of TLR-mediated NF-kappaB signaling. J Immunol 193(6): 2994-3002. 10.4049/jimmunol.1302600
49. Chang YF, Chuang HY, Hsu CH, Liu RS, Gambhir SS, Hwang JJ (2012). Immunomodulation of curcumin on adoptive therapy with T cell functional imaging in mice. Cancer Prev Res (Phila) 5(3): 444-452. 10.1158/1940-6207.CAPR-11-0308
50. Dai Y, Kato M, Takeda K, Kawamoto Y, Akhand AA, Hossain K, Suzuki H, Nakashima I (2001). T-cell-immunity-based inhibitory effects of orally administered herbal medicine juzen-taiho-to on the growth of primarily developed melanocytic tumors in RET-transgenic mice. J Invest Dermatol 117(3): 694-701. 10.1046/j.0022-202x.2001.01457.x
114. Yoshida Y, Wang MQ, Liu JN, Shan BE, Yamashita U (1997). Immunomodulating activity of Chinese medicinal herbs and Oldenlandia diffusa in particular. Int J Immunopharmacol 19(7): 359-370. 10.1016/s0192-0561(97)00076-3